Envista (NYSE:NVST) Updates FY 2025 Earnings Guidance

Envista (NYSE:NVST) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.950-1.050 for the period, compared to the consensus estimate of 1.120. The company issued revenue guidance of -.

Envista Trading Down 3.4 %

Shares of Envista stock traded down $0.75 during trading on Friday, hitting $21.05. The company’s stock had a trading volume of 770,432 shares, compared to its average volume of 2,212,870. The stock has a market cap of $3.62 billion, a price-to-earnings ratio of -2.71, a price-to-earnings-growth ratio of 1.82 and a beta of 1.34. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. Envista has a 52 week low of $15.15 and a 52 week high of $23.06. The stock has a 50-day moving average price of $19.96 and a two-hundred day moving average price of $19.12.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Equities research analysts anticipate that Envista will post 0.72 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on NVST. Mizuho started coverage on Envista in a research note on Wednesday, December 4th. They set an “underperform” rating and a $20.00 target price for the company. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st. Morgan Stanley boosted their price objective on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a report on Thursday. Robert W. Baird lifted their price objective on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Finally, Piper Sandler increased their price target on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Envista presently has an average rating of “Hold” and an average price target of $20.21.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.